About Aspen Pharmacare (JSE:APN)
Aspen Pharmacare Holdings Limited is a South Africa-based supplier and manufacturer of branded and generic pharmaceutical products, as well as infant nutritional and consumer healthcare products. The Company's segments include International, South Africa, Asia Pacific and Sub-Saharan Africa (SSA). Its International business includes operating subsidiaries in Europe, Commonwealth of Independent States (CIS), Latin America, the Middle East and North Africa, Canada, as well as Mauritius-based Aspen Global Incorporated. The South African business provides branded, generic, over-the-counter, consumer health and infant nutritional products, which are supplied to pharmacies, retail pharmacy chains, hospitals, clinics, prescribing specialists, dispensing general practitioners, managed healthcare funders and retail stores across the private and public sectors in South Africa. Its business in Asia Pacific includes operations in Australasia, the Philippines, Taiwan and Japan.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on Equity11.09%
Return on Assets4.09%
Aspen Pharmacare (JSE:APN) Frequently Asked Questions
What is Aspen Pharmacare's stock symbol?
Aspen Pharmacare trades on the JSE under the ticker symbol "APN."
Who are Aspen Pharmacare's key executives?
Aspen Pharmacare's management team includes the folowing people:
- Stephen Bradley Saad, Group Chief Executive, Executive Director (Age 53)
- Michael Guy Attridge, Deputy Group Chief Executive, Executive Director (Age 56)
- Riaan Verster, Company Secretary & Group Governance Officer (Age 41)
- Kuseni Douglas Dlamini, Non-Executive Chairman of the Board (Age 49)
- Roy Cecil Andersen CPA, Lead Independent Non-Executive Director (Age 69)
- Christopher Nattle Mortimer, Non-Executive Director (Age 56)
- David Redfern, Non-Executive Director (Age 51)
- John Frederick Buchanan, Non-Executive Independent Director (Age 72)
Has Aspen Pharmacare been receiving favorable news coverage?
Media coverage about APN stock has been trending somewhat positive on Wednesday, Accern reports. The research firm identifies positive and negative media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Aspen Pharmacare earned a news sentiment score of 0.18 on Accern's scale. They also gave media stories about the company an impact score of 46.03 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.
How do I buy shares of Aspen Pharmacare?
Shares of APN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Aspen Pharmacare's stock price today?
One share of APN stock can currently be purchased for approximately $25,697.00.
How big of a company is Aspen Pharmacare?
Aspen Pharmacare has a market capitalization of $117.29 billion.
How can I contact Aspen Pharmacare?
Aspen Pharmacare's mailing address is Woodmead, JOHANNESBURG, 2194, South Africa. The company can be reached via phone at +27-11-2396100.
MarketBeat Community Rating for Aspen Pharmacare (APN)MarketBeat's community ratings are surveys of what our community members think about Aspen Pharmacare and other stocks. Vote "Outperform" if you believe APN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APN will underperform the S&P 500 over the long term. You may vote once every thirty days.
Aspen Pharmacare (JSE:APN) Analyst Ratings History
(Data available from 4/25/2016 forward)
Aspen Pharmacare (JSE:APN) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Aspen Pharmacare (JSE APN) Insider Trading and Institutional Ownership History
Aspen Pharmacare (JSE APN) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
Aspen Pharmacare (JSE APN) News Headlines
Aspen Pharmacare (JSE:APN) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Aspen Pharmacare (JSE APN) Stock Chart for Wednesday, April, 25, 2018